Teva Pharmaceuticals USA, Inc. v. Becerra

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA TEVA PHARMACEUTICALS USA, INC., Plaintiff, Civil Action No. 25 - 113 (SLS) v. Judge Sparkle L. Sooknanan ROBERT F. KENNEDY, et al.,1 Defendants. MEMORANDUM OPINION This case is one of several challenges to the validity of the 2022 Inflation Reduction Act’s Drug Price Negotiation Program, which establishes a methodology to determine the price at which Medicare will reimburse payments for drug costs incurred by Medicare beneficiaries.2 The goal of the Drug Price Negotiation Program is to set the lowest maximum fair price that Medicare…